Fact CheckerSign in

NCT06166420Completed

Home-based Cervical Cancer Screening Project

Offering Home-based Versus Hospital-based HPV Counseling and Testing for Cervical Cancer Screening in Rural West Region of Cameroon: a Randomised Cluster Trial

Source: ClinicalTrials.gov · Last updated 15 Jan 2025

Brief summary (registry, in English)

Cervical cancer is a public health problem in Cameroon.In 2020, the country had a crude incidence of 20.2 per 100 000 women for an incidence to mortality ratio of 0.65. As for now, the country does not have a national screening program to combat the disease. Only 6% of cameroonian women have once been screened for cervical cancer. In order to increase screening uptake so as to reach 70% recommended by the World Health Organization (WHO), a home-based cervical cancer screening approach is proposed. The objective of our study is to compare two recruitment strategies for cervical cancer screening in rural Cameroon.

Status (registry)
Completed
Study type
Interventional
Enrollment
2079 (actual)
First submitted
4 Dec 2023
Start date
27 Mar 2023
Primary completion date
31 Aug 2024
Lead sponsor
Prof. Patrick Petignat
NCT number
NCT06166420

What you commit to

  • Study type: Interventional
  • Participants enrolled: 2079
  • From 27 Mar 2023 to the primary completion date, 31 Aug 2024
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Previous hysterectomy

Other illness

  • Symptoms of cervical cancer (e.g. metrorrhagia, known pelvic mass)
  • Severe pre-existing medical conditions (e.g. advanced cancer, terminal renal failure)
  • Known cervical cancer

Other

  • Women who are not able to comply with the study protocol.

Who the study is looking for

  • Women aged 30-49 years
  • Ability to understand study procedures and accepting voluntarily to participate by signing an informed consent form (ICF).
    • Non-inclusion criteria:
  • Pregnancy at the time of screening
  • History of cervical cancer screening by HPV test of less than 5 years (for HIV-negative women) or less than 3 years (for HIV positive women).
  • Intra-vaginal treatment

Age in the registry: 30 years to 49 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Dschang District Hospital
Coordinator of this site? Confirm its status
DschangCameroonUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.